1. A new orally active, selective phosphodiesterase inhibitor, with beclomethasone propionate in asthma control;Albrecht;Eur. Respir. J.,2002
2. Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation;Ariga;J. Immunol.,2004
3. Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokers;Barber;Am. J. Physiol., Lung Cell. Mol. Physiol.,2004
4. Association of the anti-inflammatory activity of phosphodiesterase 4 (PDE4) inhibitors with either inhibition of PDE4 catalytic activity or competition for [3H]rolipram binding;Barnette;Biochem. Pharmacol.,1996
5. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms;Beavo;Physiol. Rev.,1995